THE UTILITY OF SOX ANTIBODIES FOR CANCER PREDICTION IN PATIENTS WITH PARANEOPLASTIC NEUROLOGICAL DISORDERS

THE UTILITY OF SOX ANTIBODIES FOR CANCER PREDICTION IN PATIENTS WITH PARANEOPLASTIC NEUROLOGICAL DISORDERS

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Maddison, P, Titulaer, M, Verschuuren, J, Gozzard, P, Lang, B, Willcox, N, Vincent, A, Irani, SR, Chapman, C
Μορφή:	Conference item
Έκδοση:	2012

Παρόμοια τεκμήρια

The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders
ανά: Maddison, P, κ.ά.
Έκδοση: (2018)

Antibodies associated with paraneoplastic neurological disorders.
ανά: Vincent, A
Έκδοση: (2005)

Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies
ανά: Cristina Arnaldos-Pérez, κ.ά.
Έκδοση: (2023-05-01)

Paraneoplastic neurological autoimmunity and survival in small-cell lung cancer.
ανά: Maddison, P, κ.ά.
Έκδοση: (2008)

Paraneoplastic neurological syndromes: a practical approach to diagnosis and management
ανά: Binks, S, κ.ά.
Έκδοση: (2021)

ANTI-HU PARANEOPLASTIC SENSORY NEURONOPATHY WITH UNDERLYING SQUAMOUS CELL CARCINOMA OF THE LUNG
ανά: Gozzard, P, κ.ά.
Έκδοση: (2010)

Recommended diagnostic criteria for paraneoplastic neurological syndromes.
ανά: Graus, F, κ.ά.
Έκδοση: (2004)

Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes.
ανά: Graus, F, κ.ά.
Έκδοση: (2005)

Review: Progress in the management of paraneoplastic neurological disorders
ανά: Hamid Sadeghian, κ.ά.
Έκδοση: (2010-01-01)

Paraneoplastic neurological syndromes. State of the art
ανά: Giometto, B, κ.ά.
Έκδοση: (2006)

Paraneoplastic neurological syndromes
ανά: Antoine Jean-Christophe, κ.ά.
Έκδοση: (2007-05-01)

Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations
ανά: Raquel Ruiz-García, κ.ά.
Έκδοση: (2019-04-01)

N-methyl-d-aspartate antibody encephalitis: Temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
ανά: Irani, SR, κ.ά.
Έκδοση: (2010)

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.
ανά: Irani, SR, κ.ά.
Έκδοση: (2010)

Diagnosis of paraneoplastic neurological syndromes
ανά: Camilo E Fadul MD
Έκδοση: (2007-07-01)

Diagnosis of paraneoplastic neurological syndromes
ανά: Camilo E Fadul MD
Έκδοση: (2007-07-01)

PDE10A antibodies in autoimmune encephalitis: a possible marker of cancer immunotherapy?
ανά: Titulaer, MJ, κ.ά.
Έκδοση: (2019)

Antiganglioside antibodies and paraneoplastic neuromuscular junction disorder?
ανά: Noushin Jazebi, κ.ά.
Έκδοση: (2020-12-01)

EARLY AND CONTINUED TREATMENT OF N-METHYL D-ASPARTATE RECEPTOR-ANTIBODY ENCEPHALITIS OPTIMISES OUTCOME OF A PREDOMINANTLY NON-PARANEOPLASTIC DISEASE
ανά: Irani, SR, κ.ά.
Έκδοση: (2009)

An overview on CV2/CRMP5 antibody-associated paraneoplastic neurological syndromes
ανά: Sai Wang, κ.ά.
Έκδοση: (2023-01-01)

Anti-Ma2-antibody-associated encephalitis: An atypical paraneoplastic neurologic syndrome
ανά: Bogna Targonska, κ.ά.
Έκδοση: (2018-05-01)

Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study.
ανά: Paul Gozzard, κ.ά.
Έκδοση: (2015-01-01)

Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes
ανά: Daniel Chiu, κ.ά.
Έκδοση: (2023-07-01)

Neurological manifestation of cancer – paraneoplastic syndromes
ανά: Szklener Katarzyna, κ.ά.
Έκδοση: (2021-06-01)

Role of ion channel autoantibodies in NK-cell antibody-dependent anti-tumour immunity in patients with paraneoplastic Lambert-Eaton syndrome
ανά: Tschernatsch, M, κ.ά.
Έκδοση: (2009)

Simultaneous paraneoplastic cerebellar degeneration, Lambert-Eaton syndrome and neuropathy associated with AGNA/anti-SOX1 and VGCC antibodies
ανά: Jonas Feldheim, κ.ά.
Έκδοση: (2021-05-01)

Anti-Ma2 Antibody-Associated Paraneoplastic Neurological Syndromes: A Pilot Study
ανά: Yi Guo, κ.ά.
Έκδοση: (2021-11-01)

Antibody‐positive autoimmune encephalitis and paraneoplastic neurological syndrome: A Swedish case series
ανά: Sonja Kosek, κ.ά.
Έκδοση: (2024-05-01)

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
ανά: Irani, S, κ.ά.
Έκδοση: (2010)

Autoimmune and paraneoplastic seizures
ανά: Wagner, B, κ.ά.
Έκδοση: (2024)

Paraneoplastic neurologic syndrome: A practical approach
ανά: Sudheeran Kannoth
Έκδοση: (2012-01-01)

Ovarian Teratoma-Related Paraneoplastic Neurological Syndromes
ανά: Jingfang Lin, κ.ά.
Έκδοση: (2022-05-01)

Paraneoplastic neurological syndromes: clinical presentations and management
ανά: Michelle F. Devine, κ.ά.
Έκδοση: (2021-01-01)

Predicting disability and mortality in CV2/CRMP5‐IgG associated paraneoplastic neurologic disorders
ανά: Sanem P. Uysal, κ.ά.
Έκδοση: (2024-03-01)

A case of paraneoplastic neurological syndrome expressing dual antineuronal antibodies: Anti-hu and recoverin
ανά: Ho-Sung Ryu, κ.ά.
Έκδοση: (2020-01-01)

P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer.
ανά: Graus, F, κ.ά.
Έκδοση: (2002)

Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia.
ανά: Becker, E, κ.ά.
Έκδοση: (2012)

Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia.
ανά: Becker, E, κ.ά.
Έκδοση: (2012)

Thymoma and paraneoplastic myasthenia gravis.
ανά: Marx, A, κ.ά.
Έκδοση: (2010)

Clinical characteristics and immunotherapy response in paraneoplastic neurologic syndrome patients with increased number of high-risk antibodies
ανά: Gong Wang, κ.ά.
Έκδοση: (2025-01-01)